8-KEarnings & ResultsExhibits & Filings

BIOGEN INC. 8-K Report, Financial Results (Aug 1, 2024)

Filed August 1, 2024For Securities:BIIB

Summary

Biogen Inc. (BIIB) has filed an 8-K on August 1, 2024, to report its financial results for the second quarter ended June 30, 2024. The core of this filing is the press release, furnished as Exhibit 99.1, which details the company's operational performance and financial condition. Investors should refer to this press release for the specific quantitative and qualitative information regarding the quarter's results. While the 8-K itself is a formal filing, it directs stakeholders to the accompanying press release for the critical financial data. This is a standard procedure for earnings announcements, meaning the detailed performance metrics, revenue figures, profitability, and any forward-looking statements are contained within the furnished press release, which is incorporated by reference into this filing.

Key Highlights

  • 1Biogen Inc. filed an 8-K on August 1, 2024, to announce its Q2 2024 financial results.
  • 2The filing incorporates by reference Biogen's press release dated August 1, 2024, as Exhibit 99.1.
  • 3This press release contains the company's results of operations and financial condition for the second quarter ended June 30, 2024.
  • 4Investors are directed to the press release for specific financial performance details.
  • 5The information furnished is not considered 'filed' for certain SEC provisions, a standard disclosure for earnings releases.

Frequently Asked Questions

The actual financial results for Biogen's second quarter ended June 30, 2024, are detailed in the press release dated August 1, 2024, which is furnished as Exhibit 99.1 to this 8-K filing.

This 8-K filing serves as the official notification to the SEC that Biogen has released its second-quarter financial results. It primarily directs investors and analysts to the accompanying press release for the specific performance data.

No, the 8-K filing itself is a brief report announcing the results. The detailed financial tables, operational commentary, and any forward-looking statements are found within the furnished press release (Exhibit 99.1).